The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-bromo-3',4'-bis(3-chlorophenyl)-4'H-spiro[indoline-3,5'-[1,2,4]oxadiazol]-2-one ID: ALA3797570
PubChem CID: 127046731
Max Phase: Preclinical
Molecular Formula: C21H12BrCl2N3O2
Molecular Weight: 489.16
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C1Nc2ccc(Br)cc2[C@]12ON=C(c1cccc(Cl)c1)N2c1cccc(Cl)c1
Standard InChI: InChI=1S/C21H12BrCl2N3O2/c22-13-7-8-18-17(10-13)21(20(28)25-18)27(16-6-2-5-15(24)11-16)19(26-29-21)12-3-1-4-14(23)9-12/h1-11H,(H,25,28)/t21-/m0/s1
Standard InChI Key: YGWNEVQVVZQISY-NRFANRHFSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
-0.5725 -1.9258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2776 -0.7113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5725 0.4858 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9432 0.0347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2791 0.7460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5977 0.0347 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.5977 -1.4921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2791 -2.2555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9432 -1.4921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7870 1.3706 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2665 2.8107 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.2082 2.8107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6593 1.3533 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.4776 -0.7073 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0988 4.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5927 3.9689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3847 5.2428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6775 6.5656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1783 6.6145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3863 5.3406 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0798 0.8691 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4802 -0.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9329 -0.9451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9829 0.1260 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5804 1.5710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1277 1.9448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.6282 0.6496 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
4.2549 -2.1011 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
4.5841 5.2037 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
3 2 1 6
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
1 9 1 0
4 9 2 0
10 11 1 0
11 12 2 0
12 13 1 0
3 10 1 0
3 13 1 0
2 14 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
15 20 2 0
12 15 1 0
13 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
6 27 1 0
23 28 1 0
17 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 489.16Molecular Weight (Monoisotopic): 486.9490AlogP: 5.76#Rotatable Bonds: 2Polar Surface Area: 53.93Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1CX Acidic pKa: 11.36CX Basic pKa: ┄CX LogP: 6.96CX LogD: 6.96Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.50Np Likeness Score: -0.73
References 1. Ribeiro CJA, Amaral JD, Rodrigues CMP, Moreira R, Santos MMM. (2016) Spirooxadiazoline oxindoles with promising in vitro antitumor activities, 7 (3): [10.1039/C5MD00450K ]